期刊文献+

肥厚型心肌病心肌MRI延迟强化特征分析 被引量:12

Characteristics of hypertrophic cardiomyopathy on delayed contrast-enhanced MRI
原文传递
导出
摘要 目的 搜集肥厚型心肌病患者心脏MRI资料,分析其受累心肌对比剂延迟强化特点.方法 应用心脏MR技术检查肥厚型心肌病患者,并行心肌对比剂延迟显像,依据9节段分析法分析受累心肌对比剂延迟强化节段范围及程度等.应用t检验对延迟与非延迟强化组数据进行统计学分析.结果 154例患者接受心肌对比剂延迟显像,其中受累心肌节段出现延迟强化的患者共95例,无延迟强化者59例.延迟与非延迟强化组受累节段厚度[分别为(24.8±5.5)和(20.4±3.8)mm,t=3.82,P〈0.05]以及受累节段数[分别为(3.3±1.9)和(2.4±1.7)段,t=2.26,P〈0.05]比较,前者均大于后者;而患者年龄比较,延迟强化组低于非延迟强化组[分别为(46.0±15.2)和(55.0±11.9)岁,t=-3.67,P〈0.05].按照强化的形态,弥漫性强化62例,局限性强化33例.共14例患者接受了酒精消融术治疗,所有患者术后心肌延迟显像均可见明确的局限性强化影.结论 肥厚型心肌病MR对比剂延迟强化患者在受累节段厚度、数量以及年龄等各方面都明显不同于非强化患者. Objective To analyze the characteristics of hypertrophic cardiomyopathy (HCM) on delayed contrast-enhanced cardiac magnetic resonance imaging (CMRI). Methods All patients underwent delayed contrast-enhanced CMRI. The left ventricle was divided into 9 segments to assess the location,extent and function of the hypertrophic segments. The t test was applied for the statistics. Results Of 154 patients, delayed enhancement of hypertrophic segment was found in 95 cases and non-delayed enhancement in 59 cases. The thickness and number of hypertrophic segment in patients with delayed enhancement were larger than those with non-delayed enhancement [ (24. 8 ± 5. 5 ) mm vs (20. 4 ±3.8) mm, t = 3.82, P 〈 0.05 (3.3 ± 1.9) vs (2.4 ± 1.7), t = 2. 26, P 〈 0.05 ], and the age was younger [ (46. 0 ± 15.2) years vs (55.0 ± 11.9) years, t = - 3. 67, P 〈0. 05 ]. The diffuse enhancement was found in 62 patients, and confluent enhancement in 33 patients. Confluent enhancement was found in all 14 patients after the alcohol ablation procedure. Conclusion The age, thickness and number of hypertrophic segments in patients with delayed enhancement are different from those with non-delayed enhancement.
出处 《中华放射学杂志》 CAS CSCD 北大核心 2010年第9期903-906,共4页 Chinese Journal of Radiology
关键词 心肌病 肥厚型 磁共振成像 图像增强 Cardiomyopathy, hypertrophic Magnetic resonance imaging Image enhancement
  • 相关文献

参考文献13

  • 1Rickers C,Wilke NM,Jerosch-Herold M,et al.Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy.Circulation,2005,112:855-861.
  • 2Moon JC,Fisher NG,McKenna WJ,et al.Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with non-diagnostic echocardiography.Heart,2004,90:645-649.
  • 3韦云青,赵世华,陆敏杰,蒋世良,闫朝武,张岩,王宏宇.心尖肥厚型心肌病的MRI诊断[J].中华放射学杂志,2007,41(8):800-804. 被引量:35
  • 4闫朝武,赵世华,陆敏杰,蒋世良,韦云青,李世国,祁晓欧,张岩,刘玉清.左室心肌致密化不全的临床特征和磁共振成像表现[J].中华心血管病杂志,2006,34(12):1081-1084. 被引量:52
  • 5Klues HG,Schiffers A,Maron BJ.Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy:morphologic observations and significance as assessed by two-dimensiomal echocardiography in 600 patients.J Am Coll Cardiol,1995,26:1699-1708.
  • 6Dimitrow PP,Klimeczek P,Vliegenthart R,et al.Late hyperenhancement in gadolinium-enhanced magnetic resonance imaging:comparison of hypertrophic cardiomyopathy patients with and without nonsustained ventricular tachycardia.Int J Cardiovasc Imaging,2008,24:77-83.
  • 7Choudhury L,Mahrholdt H,Wagner A,et al.Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy.J Am Coll Cardiol,2002,40:2156-2164.
  • 8Bogaert J,Goldstein M,Tannouri F,et al.Original report:late myocardial enhancement in hypertrophic cardiomyopathy with contrast-enhanced MR imaging.A JR,2003,180:981-985.
  • 9Tsukihashi H,Ishibashi Y,Shimada T,et al.Changes in gadolinium-DTPA enhanced magnetic resonance signal intensity ratio in hypertrophic cardiomyopathy.J Cardiol,1994,24:185-191.
  • 10Koito H,Suzuki J,Nakamori H,et al.Clinical significance of abnormal high signal intensity of left ventricular myocardium by gadolinium-diethylenetriaminepenta-acetic acid enhanced magnetic resonance imaging in hypertrophic cardiomyopathy.J Cardiol,1995,25:163-170.

二级参考文献28

  • 1赵世华,陆敏杰,张岩,蒋世良,黄连军,王红宇,吴言伶,杜茉佳,刘玉清.1.5 T高端MR在心血管病诊断中的应用[J].中华放射学杂志,2005,39(6):577-581. 被引量:30
  • 2苗翠莲,张兆琪,郭曦,王珏,宴子旭,赵轶柯.孤立性心肌致密化不全的MRI诊断[J].中华放射学杂志,2005,39(6):588-592. 被引量:19
  • 3Richardson P,McKenna W,Bristow M,et al.Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies.Circulation,1996,93:841-842.
  • 4Engberding R,Bender F.Identification of a rare congenital anomaly of the myocardium by two-dimensional echocardiography:persistence of isolated myocardial sinusoids.Am J Cardiol,1984,53:1733-1734.
  • 5Oechslin EN,Attenhofer Jost CH,Rojas JR,et al.Long-term follow-up of 34 adults with isolated left ventricular noncompaction:a distinct cardiomyopathy with poor prognosis.J Am Coll Cardiol,2000,36:493-500.
  • 6Ritter M,Oechslin E,Sutsch G,et al.Isolated noncompaction of the myocardium in adults.Mayo Clin Proc,1997,72:26-31.
  • 7Chin TK,Perloff JK,Williams RG,et al.Isolated noncompaction of left ventricular myocardium.A study of eight cases.Circulation,1990,82:507-513.
  • 8Jenni R,Oechslin E,Schneider J,et al.Echocardiographic and pathoanatomical characteristics of isolated left ventricular non-compaction:a step towards classification as a distinct cardiomyopathy.Heart,2001,86:666-671.
  • 9Agmon Y,Connolly HM,Olson LJ,et al.Noncompaction of the ventricular myocardium.J Am Soc Echocardiogr,1999,12:859-863.
  • 10Vatta M,Mohapatra B,Jimenez S,et al.Mutations in Cypher/ZASP in patients with dilated cardiomyopathy and left ventricular non-compaction.J Am Coll Cardiol,2003,42:2014-2027.

共引文献85

同被引文献126

引证文献12

二级引证文献70

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部